seems to be going pretty well so far - 3 still on trial from the first cohort - decent number of partial responders (ie over the stable disease expectation) - definitely worth seeing how this goes in the P2 longer trial. Not sure whether the patients will also be late stage? Quite impressed!
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $111.8M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 22.8¢ | $735.7K | 3.164M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 806949 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 478143 | 19 |
View Market Depth
| Last trade - 14.39pm 01/08/2025 (20 minute delay) ? |
| ATX (ASX) Chart |